Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer
The New England Journal of Medicine publishes the results of the FLAURA trial on osimertinib in untreated EGFR-mutated advanced non-small cell lung cancer.
The New England Journal of Medicine publishes the results of the FLAURA trial on osimertinib in untreated EGFR-mutated advanced non-small cell lung cancer.